Seres Therapeutics, Inc.
MCRB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $8,204 | -$19,855 | $32,682 | -$15,637 |
| Dep. & Amort. | $1,044 | $1,059 | $1,076 | $1,085 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $2,340 | $2,819 | $3,765 |
| Change in WC | -$11,649 | $1,103 | -$11,712 | -$30,126 |
| Other Non-Cash | $4,607 | $2,064 | $2,045 | $2,031 |
| Operating Cash Flow | $2,206 | -$13,289 | $26,910 | -$38,882 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$181 | -$34 | -$90 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$8 | -$181 | -$34 | -$90 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $127,905 |
| Stock Issued | $61 | $0 | $1,180 | $1,737 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$127,905 |
| Financing Cash Flow | $61 | $0 | $1,180 | $1,737 |
| Forex Effect | $0 | $0 | $0 | -$1 |
| Net Chg. in Cash | $2,259 | -$13,470 | $28,056 | -$37,236 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $45,379 | $67,517 | $39,461 | $76,697 |
| End Cash | $47,638 | $54,047 | $67,517 | $39,461 |
| Free Cash Flow | $2,198 | -$13,470 | $26,876 | -$38,972 |